BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20181627)

  • 1. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
    Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
    Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
    Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
    Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of secreted proteins of non-small cell lung cancer.
    Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
    Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
    He P; Naka T; Serada S; Fujimoto M; Tanaka T; Hashimoto S; Shima Y; Yamadori T; Suzuki H; Hirashima T; Matsui K; Shiono H; Okumura M; Nishida T; Tachibana I; Norioka N; Norioka S; Kawase I
    Cancer Sci; 2007 Aug; 98(8):1234-40. PubMed ID: 17506794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines.
    Trojanowicz B; Winkler A; Hammje K; Chen Z; Sekulla C; Glanz D; Schmutzler C; Mentrup B; Hombach-Klonisch S; Klonisch T; Finke R; Köhrle J; Dralle H; Hoang-Vu C
    J Mol Endocrinol; 2009 Mar; 42(3):249-60. PubMed ID: 19060179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.
    Tilleman K; Van Beneden K; Dhondt A; Hoffman I; De Keyser F; Veys E; Elewaut D; Deforce D
    Proteomics; 2005 May; 5(8):2247-57. PubMed ID: 15846842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.
    Tsai ST; Chien IH; Shen WH; Kuo YZ; Jin YT; Wong TY; Hsiao JR; Wang HP; Shih NY; Wu LW
    Eur J Cancer; 2010 Jun; 46(9):1712-23. PubMed ID: 20435467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.
    Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG
    Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
    Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.
    Grandjean M; Sermeus A; Branders S; Defresne F; Dieu M; Dupont P; Raes M; De Ridder M; Feron O
    PLoS One; 2013; 8(10):e76508. PubMed ID: 24130777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.
    Grandjean M; Dieu M; Raes M; Feron O
    J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening human gastric carcinoma-associated antigens by serologic proteome analysis].
    Zeng X; Liao AJ; Tang HL; Yi L; Xie N; Su Q
    Ai Zheng; 2007 Oct; 26(10):1080-4. PubMed ID: 17927877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
    Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
    BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteome analysis of autoantibodies in sera of patients with cancer].
    Ueda K
    Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis].
    Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.